EPAT General Discussion, page-1056

On holidays in Europe so I haven’t been watching this pullback too closely. It’s been indiscriminate to all small caps which are the first to go in a volatile market.

The only thing which will make this move are some decent contract wins or some left wing FDA news which must be close, all the pre take off checklists have been ticked.

The DSA Agreement will be getting into full swing, PCK can now market themselves as a clinical support system as well as a pain detection tool. Australia alone has 413,000 people with Dementia at $10 a month = c.50M a year. The market here is massive especially if they can release a home consumer app later this year.

The patient will be rewarded as the hockey stick growth arrives.